136 related articles for article (PubMed ID: 21138870)
1. Dietary curcumin attenuates glioma growth in a syngeneic mouse model by inhibition of the JAK1,2/STAT3 signaling pathway.
Weissenberger J; Priester M; Bernreuther C; Rakel S; Glatzel M; Seifert V; Kögel D
Clin Cancer Res; 2010 Dec; 16(23):5781-95. PubMed ID: 21138870
[TBL] [Abstract][Full Text] [Related]
2. Stat3 inhibition activates tumor macrophages and abrogates glioma growth in mice.
Zhang L; Alizadeh D; Van Handel M; Kortylewski M; Yu H; Badie B
Glia; 2009 Oct; 57(13):1458-67. PubMed ID: 19306372
[TBL] [Abstract][Full Text] [Related]
3. Two small molecule compounds, LLL12 and FLLL32, exhibit potent inhibitory activity on STAT3 in human rhabdomyosarcoma cells.
Wei CC; Ball S; Lin L; Liu A; Fuchs JR; Li PK; Li C; Lin J
Int J Oncol; 2011 Jan; 38(1):279-85. PubMed ID: 21109950
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of STAT3 and ErbB2 suppresses tumor growth, enhances radiosensitivity, and induces mitochondria-dependent apoptosis in glioma cells.
Gao L; Li F; Dong B; Zhang J; Rao Y; Cong Y; Mao B; Chen X
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1223-31. PubMed ID: 20610043
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of platelet-derived growth factor-mediated signal transduction and tumor growth by N-[4-(trifluoromethyl)-phenyl]5-methylisoxazole-4-carboxamide.
Shawver LK; Schwartz DP; Mann E; Chen H; Tsai J; Chu L; Taylorson L; Longhi M; Meredith S; Germain L; Jacobs JS; Tang C; Ullrich A; Berens ME; Hersh E; McMahon G; Hirth KP; Powell TJ
Clin Cancer Res; 1997 Jul; 3(7):1167-77. PubMed ID: 9815796
[TBL] [Abstract][Full Text] [Related]
6. Orthotopic transplantation of v-src-expressing glioma cell lines into immunocompetent mice: establishment of a new transplantable in vivo model for malignant glioma.
Smilowitz HM; Weissenberger J; Weis J; Brown JD; O'Neill RJ; Laissue JA
J Neurosurg; 2007 Apr; 106(4):652-9. PubMed ID: 17432718
[TBL] [Abstract][Full Text] [Related]
7. Novel STAT3 phosphorylation inhibitors exhibit potent growth-suppressive activity in pancreatic and breast cancer cells.
Lin L; Hutzen B; Zuo M; Ball S; Deangelis S; Foust E; Pandit B; Ihnat MA; Shenoy SS; Kulp S; Li PK; Li C; Fuchs J; Lin J
Cancer Res; 2010 Mar; 70(6):2445-54. PubMed ID: 20215512
[TBL] [Abstract][Full Text] [Related]
8. Combined inhibition of Janus kinase 1/2 for the treatment of JAK2V617F-driven neoplasms: selective effects on mutant cells and improvements in measures of disease severity.
Liu PC; Caulder E; Li J; Waeltz P; Margulis A; Wynn R; Becker-Pasha M; Li Y; Crowgey E; Hollis G; Haley P; Sparks RB; Combs AP; Rodgers JD; Burn TC; Vaddi K; Fridman JS
Clin Cancer Res; 2009 Nov; 15(22):6891-900. PubMed ID: 19887489
[TBL] [Abstract][Full Text] [Related]
9. Myricetin directly targets JAK1 to inhibit cell transformation.
Kumamoto T; Fujii M; Hou DX
Cancer Lett; 2009 Mar; 275(1):17-26. PubMed ID: 18995957
[TBL] [Abstract][Full Text] [Related]
10. Evidence that curcumin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: role of Akt and extracellular signal-regulated kinase signaling pathways.
Aoki H; Takada Y; Kondo S; Sawaya R; Aggarwal BB; Kondo Y
Mol Pharmacol; 2007 Jul; 72(1):29-39. PubMed ID: 17395690
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of decoy-ODN targeting activated STAT3 on human glioma growth in vivo.
Shen J; Li R; Li G
In Vivo; 2009; 23(2):237-43. PubMed ID: 19414409
[TBL] [Abstract][Full Text] [Related]
12. An anticancer effect of curcumin mediated by down-regulating phosphatase of regenerating liver-3 expression on highly metastatic melanoma cells.
Wang L; Shen Y; Song R; Sun Y; Xu J; Xu Q
Mol Pharmacol; 2009 Dec; 76(6):1238-45. PubMed ID: 19779032
[TBL] [Abstract][Full Text] [Related]
13. New role of (-)-epicatechin in enhancing the induction of growth inhibition and apoptosis in human lung cancer cells by curcumin.
Saha A; Kuzuhara T; Echigo N; Suganuma M; Fujiki H
Cancer Prev Res (Phila); 2010 Aug; 3(8):953-62. PubMed ID: 20606042
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor-induced ovarian carcinoma cell migration is associated with JAK2/STAT3 signals and changes in the abundance and localization of alpha6beta1 integrin.
Colomiere M; Findlay J; Ackland L; Ahmed N
Int J Biochem Cell Biol; 2009 May; 41(5):1034-45. PubMed ID: 18930836
[TBL] [Abstract][Full Text] [Related]
15. The role of tregs in human glioma patients and their inhibition with a novel STAT-3 inhibitor.
Heimberger AB; Kong LY; Abou-Ghazal M; Reina-Ortiz C; Yang DS; Wei J; Qiao W; Schmittling RJ; Archer GE; Sampson JH; Hiraoka N; Priebe W; Fuller GN; Sawaya R
Clin Neurosurg; 2009; 56():98-106. PubMed ID: 20214040
[No Abstract] [Full Text] [Related]
16. Chrysin suppresses IL-6-induced angiogenesis via down-regulation of JAK1/STAT3 and VEGF: an in vitro and in ovo approach.
Lin CM; Shyu KG; Wang BW; Chang H; Chen YH; Chiu JH
J Agric Food Chem; 2010 Jun; 58(11):7082-7. PubMed ID: 20443595
[TBL] [Abstract][Full Text] [Related]
17. Auranofin blocks interleukin-6 signalling by inhibiting phosphorylation of JAK1 and STAT3.
Kim NH; Lee MY; Park SJ; Choi JS; Oh MK; Kim IS
Immunology; 2007 Dec; 122(4):607-14. PubMed ID: 17645497
[TBL] [Abstract][Full Text] [Related]
18. Luteolin promotes degradation in signal transducer and activator of transcription 3 in human hepatoma cells: an implication for the antitumor potential of flavonoids.
Selvendiran K; Koga H; Ueno T; Yoshida T; Maeyama M; Torimura T; Yano H; Kojiro M; Sata M
Cancer Res; 2006 May; 66(9):4826-34. PubMed ID: 16651438
[TBL] [Abstract][Full Text] [Related]
19. A novel inhibitor of the STAT3 pathway induces apoptosis in malignant glioma cells both in vitro and in vivo.
Iwamaru A; Szymanski S; Iwado E; Aoki H; Yokoyama T; Fokt I; Hess K; Conrad C; Madden T; Sawaya R; Kondo S; Priebe W; Kondo Y
Oncogene; 2007 Apr; 26(17):2435-44. PubMed ID: 17043651
[TBL] [Abstract][Full Text] [Related]
20. 8-benzyl-4-oxo-8-azabicyclo[3.2.1]oct-2-ene-6,7-dicarboxylic acid (SD-1008), a novel janus kinase 2 inhibitor, increases chemotherapy sensitivity in human ovarian cancer cells.
Duan Z; Bradner J; Greenberg E; Mazitschek R; Foster R; Mahoney J; Seiden MV
Mol Pharmacol; 2007 Nov; 72(5):1137-45. PubMed ID: 17675586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
